HPLC Method Development of Fingolimod: A new RP HPLC method developmental & validation of Fingolimod HCL - Brossura
Sinossi
Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in pharmacy or Analytical Chemistry or any other courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Risultati della ricerca per HPLC Method Development of Fingolimod: A new RP HPLC...
Foto dell'editore
HPLC Method Development of Fingolimod
Editore:
LAP Lambert Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
Nuovo
Brossura
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New. Codice articolo ABLIING23Mar3113020301056
Compra nuovo
EUR 37,20
Spese di spedizione:
EUR 3,44
In U.S.A.
Quantità: Più di 20 disponibili
Foto dell'editore
HPLC Method Development of Fingolimod
Print on DemandDa: PBShop.store US, Wood Dale, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
PAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice articolo L0-9783659693090
Compra nuovo
EUR 41,04
Spese di spedizione:
GRATIS
In U.S.A.
Quantità: Più di 20 disponibili
Foto dell'editore
HPLC Method Development of Fingolimod
Print on DemandDa: PBShop.store UK, Fairford, GLOS, Regno Unito
Valutazione del venditore 5 su 5 stelle
PAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice articolo L0-9783659693090
Compra nuovo
EUR 39,91
Spese di spedizione:
EUR 3,76
Da: Regno Unito a: U.S.A.
Quantità: Più di 20 disponibili
Foto dell'editore
HPLC Method Development of Fingolimod
Editore:
LAP Lambert Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
Nuovo
Brossura
Da: Ria Christie Collections, Uxbridge, Regno Unito
Valutazione del venditore 5 su 5 stelle
Condizione: New. In. Codice articolo ria9783659693090_new
Compra nuovo
EUR 37,47
Spese di spedizione:
EUR 13,68
Da: Regno Unito a: U.S.A.
Quantità: Più di 20 disponibili
Foto dell'editore
HPLC Method Development of Fingolimod
Editore:
LAP Lambert Academic Publishing 2015-05-18, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
Nuovo
Paperback
Da: Chiron Media, Wallingford, Regno Unito
Valutazione del venditore 4 su 5 stelle
Paperback. Condizione: New. Codice articolo 6666-IUK-9783659693090
Compra nuovo
EUR 35,81
Spese di spedizione:
EUR 17,68
Da: Regno Unito a: U.S.A.
Quantità: 10 disponibili
Immagini fornite dal venditore
HPLC Method Development of Fingolimod
Editore:
LAP LAMBERT Academic Publishing Mai 2015, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
Nuovo
Taschenbuch
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in pharmacy or Analytical Chemistry or any other courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers. 60 pp. Englisch. Codice articolo 9783659693090
Compra nuovo
EUR 35,90
Spese di spedizione:
EUR 23,00
Da: Germania a: U.S.A.
Quantità: 2 disponibili
Immagini fornite dal venditore
HPLC Method Development of Fingolimod
Editore:
LAP LAMBERT Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
Nuovo
Brossura
Da: moluna, Greven, Germania
Valutazione del venditore 4 su 5 stelle
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Ghosh SomsubhraSomsubhra Ghosh is Assistant Professor in theDepartment of Pharmaceutical Analysis & QualityAssurance in Bharat Technology,Uluberia,Howrah, W.B. He has written 3 books & 34 papers indifferent reputed National & Interna. Codice articolo 159143802
Compra nuovo
EUR 34,25
Spese di spedizione:
EUR 48,99
Da: Germania a: U.S.A.
Quantità: Più di 20 disponibili
Immagini fornite dal venditore
HPLC Method Development of Fingolimod
Editore:
LAP LAMBERT Academic Publishing Mai 2015, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
Nuovo
Taschenbuch
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in pharmacy or Analytical Chemistry or any other courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers.Books on Demand GmbH, Überseering 33, 22297 Hamburg 60 pp. Englisch. Codice articolo 9783659693090
Compra nuovo
EUR 39,90
Spese di spedizione:
EUR 60,00
Da: Germania a: U.S.A.
Quantità: 1 disponibili
Immagini fornite dal venditore
HPLC Method Development of Fingolimod : A new RP HPLC method developmental & validation of Fingolimod HCL
Editore:
LAP LAMBERT Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
Nuovo
Taschenbuch
Da: AHA-BUCH GmbH, Einbeck, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for treating multiple sclerosis. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Till now very few methods are available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in pharmacy or Analytical Chemistry or any other courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of RP- HPLC is also included. Wish happy reading to all readers. Codice articolo 9783659693090
Compra nuovo
EUR 39,90
Spese di spedizione:
EUR 60,54
Da: Germania a: U.S.A.
Quantità: 1 disponibili
Immagini fornite dal venditore
HPLC Method Development of Fingolimod | A new RP HPLC method developmental & validation of Fingolimod HCL
Editore:
LAP LAMBERT Academic Publishing, 2015
ISBN 10: 365969309X
ISBN 13: 9783659693090
Nuovo
Taschenbuch
Da: preigu, Osnabrück, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. HPLC Method Development of Fingolimod | A new RP HPLC method developmental & validation of Fingolimod HCL | Somsubhra Ghosh (u. a.) | Taschenbuch | 60 S. | Englisch | 2015 | LAP LAMBERT Academic Publishing | EAN 9783659693090 | Verantwortliche Person für die EU: OmniScriptum GmbH & Co. KG, Bahnhofstr. 28, 66111 Saarbrücken, info[at]akademikerverlag[dot]de | Anbieter: preigu. Codice articolo 104616497
Compra nuovo
EUR 36,95
Spese di spedizione:
EUR 70,00
Da: Germania a: U.S.A.
Quantità: 5 disponibili